Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
12/2003
12/04/2003US20030225071 N-heterocyclic amides and carbamates
12/04/2003US20030225042 Antipicornaviral compounds and compositions, their uses, and materials for their synthesis
12/04/2003US20030225010 Novel compositions and methods for the regulation of proliferation of stem cells
12/04/2003US20030224999 Novel indole peptidomimetics as thrombin receptor antagonists
12/04/2003US20030224987 Binding to formyl peptide receptor or formyl peptide receptor-like 1
12/04/2003US20030224977 Inhibitors of the HCV NS3 protease.
12/04/2003US20030224453 Structural models for cytoplasmic domains of transmembrane receptors
12/04/2003US20030224368 Crystallizable compositions comprising a caspase-7
12/04/2003US20030224352 Comprises lymphadenopathy viral sequences for diagnosis of aquired immuno-depressive syndromes
12/03/2003EP1367063A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/03/2003EP1367062A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/03/2003EP1367061A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
12/03/2003EP1366765A1 Use of matrix metalloproteinase inhibitors for treating neurological disorders and promoting wound healing
12/03/2003EP1366076A2 Compounds and methods for modulating desmosomal cadherin-mediated functions
12/03/2003EP1366022A1 Rgd-analog non-peptidic molecules having anti-adhesive, anti-migration and anti-proliferative effects
12/03/2003EP1366017A2 Non-natural basic amino acids, their preparation and use
12/03/2003EP1365789A1 Compounds comprising disulfide-containing peptides and nitrogenous bases, and medical uses thereof
12/03/2003EP1365787A2 New uses for amino acid anticonvulsants for treatment of pain
12/03/2003EP1187847B1 Streptogramin derivatives, preparation and compositions containing them
12/03/2003CN1129605C Modified aminoacids, pharmaceuticals containing these compounds and mehtod for their prodn
12/03/2003CN1129604C Amino acid derivatives and their use as thrombin inhibitors
12/03/2003CN1129603C Heterocycles, its preparation, application and medicine contanining same
12/02/2003US6657073 Crystallization of α-L-aspartyl-L-phenylalanine methyl ester
12/02/2003US6656965 HIV protease inhibitors based on amino acid derivatives
12/02/2003US6656911 Serine protease inhibitors
12/02/2003US6656910 Substituted oxadiazole, thiadiazoles and triazole peptoids for treating adult respiratory distress syndrome, septic shock, and myocardial ischemia-reperfusion injury
12/02/2003US6656906 Hybrid polypeptides with enhanced pharmacokinetic properties
12/02/2003US6656905 Cyclic tetrapeptide compound and use thereof
12/02/2003US6656448 Matrix metalloproteinase inhibitors
11/2003
11/27/2003WO2003097836A1 Method of accumulating arbitrary peptide in plant protein granules
11/27/2003WO2003097670A1 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containing same
11/27/2003WO2003097668A2 Novel process for production of the somatostatin analog, octreotide
11/27/2003WO2003097664A2 Non-covalent inhibitors of cysteine proteases with atripeptide backbone
11/27/2003WO2003097587A2 Gelling agents
11/27/2003WO2003097089A2 Attenuation of metapneumovirus
11/27/2003WO2003059942A9 Peptides and peptidomimetics having anti-proliferative activity and their use
11/27/2003WO2003059881A3 Dna minor groove binding compounds
11/27/2003WO2003059378A3 Combined use of a glp-1 compound and another drug for treating dyslipidemia
11/27/2003WO2003018636A3 Chimaeric peptides of insulin, their compositions and use in treating diabetes
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003WO2003006620A3 Linear and cyclic melanocortin receptor-specific peptides
11/27/2003WO2003000716A3 Preparation and use of amorphous lisinopril
11/27/2003US20030221222 Plant retroviral polynucleotides and methods for use thereof
11/27/2003US20030220508 An enzyme inhibitor for treating AIDS, viral infections
11/27/2003US20030220482 Novel peptide antagonist of CXCR4 derived from the N-terminus of the viral chemokine vMIP-II
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003US20030220267 Especially HIV-1 protease inhibitors; peptides containing one or more B-OH groups
11/27/2003US20030219452 HIV envelope V3-CCR5 binding site immunogen
11/27/2003US20030219447 Biologically active peptides
11/27/2003CA2486342A1 Compounds which can block the response to chemical substances or thermal stimuli or mediators of inflammation of nociceptors, production method thereof and compositions containingsame
11/27/2003CA2484295A1 Attenuation of metapneumovirus
11/26/2003EP1364960A1 Peptide derivatives
11/26/2003EP1364941A1 Gelling agents
11/26/2003EP1364647A1 Hypoglycemic agent
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363656A2 Tripeptides and tripeptide derivatives for the treatment of postlesional diseases of the nervous system
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1028977B1 Bifidus stimulating peptides and their uses
11/26/2003EP0912601B1 Suppression of immune response via inhibition of cathepsin s
11/26/2003EP0821002B1 Plant cell growth factors
11/26/2003CN1128809C Process for preparing 2-aminodicarboxylic 1-amidobenzyl ester
11/26/2003CN1128636C Pharmaceutical angiostatic dipeptide compositions and method of use thereof
11/25/2003US6653338 FSH mimetics for the treatment of infertility
11/25/2003US6653295 Protease inhibitor; viricide
11/25/2003US6652901 Sweetener compositions and uses thereof
11/25/2003CA2105014C Imidazolidine derivatives
11/24/2003CA2387644A1 1,3-oxazolium-5-oxides or their alpha-amidoketene tautomers, process of preparation and uses thereof
11/20/2003WO2003095619A2 Protein complex purification
11/20/2003WO2003095478A1 Thermostable and monoconjugatable gold cluster complexes
11/20/2003WO2003095474A2 Peptides and methods for the control of obesity
11/20/2003WO2003074546A8 Streptavidin-binding peptide
11/20/2003WO2002064734A3 Identification of target-specific folding sites in peptides and proteins
11/20/2003WO2002034915A3 Preferred segments of neural thread protein and methods of using the same
11/20/2003WO2002016407A3 Sh2 domain binding inhibitors
11/20/2003WO2001091700A8 Composition and method for enhancing elasticity of tissue
11/20/2003US20030216592 Novel intermediate for sweetener with high sweetness and process forproducing the same
11/20/2003US20030216575 Novel pyranosyl cytosines: pharmaceutical formulations and methods
11/20/2003US20030216569 Viricides; Aids therapy
11/20/2003US20030216466 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216399 A dipeptide containing bi or tri-heterocylic ring with nitrogen atom which forms amide with carbonyl group of dipeptide chain; useful for treating osteoporosis, congestive heart failure and accelerates wound healing
11/20/2003US20030216325 Novel peptides as NS3-serine protease inhibitors of hepatitis C virus
11/20/2003US20030216324 Five-member heterocyclic compounds substituted with an alpha-amino carbonyl group; antiasthma agents
11/20/2003US20030216320 Peptide-based multimeric targeted contrast agents
11/20/2003US20030216301 Such as (6R,20aS)-16-chloro-6-cyclohexyl-2,3,6,7,9,10,18,19-octahydro-1H- pyrrolo-(1,2-j)(1,4,7,10,13)-benzoxatetraazacyclohexadecine -5,8,11,20(12H,20aH)-tetrone
11/20/2003US20030216289 Treating leukemia or a solid tumor
11/20/2003CA2524862A1 Peptides and methods for the control of obesity
11/19/2003EP1362864A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
11/19/2003EP1362845A2 New process for the synthesis of N-((S)-1-carboxybutyl)-(S)-alanine esters and their use in the synthesis of perindopril
11/19/2003EP1362596A2 Inhibitor of stem cell proliferation and uses thereof
11/19/2003EP1361847A2 Bile-acid conjugates for providing sustained systemic concentrations of drugs
11/19/2003EP1060190B1 New salt forms of (2e)- 5-amino-5- methylhex-2- enoic acid n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1-(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide
11/19/2003EP0719779B1 Substituted thiazolo [3,2-alpha]azepine derivative
11/18/2003US6649784 Reductive alkylation of aspartame with aldehyde
11/18/2003US6649593 Amino acid derivatives including serine, leucine, valine, arginine, asparginine, methionine, glycine and phenylalanine units; S1 protease inhibition; modulation of cholesterol homeostasis in cells
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/18/2003US6649387 Enzymatic oxidative deamination process
11/18/2003CA2276109C Peptidomimetic inhibitors of the human cytomegalovirus protease
11/13/2003WO2003093314A2 Connective tissue stimulating peptides
11/13/2003WO2003092736A2 Peptide nucleic acid conjugates with transporter peptides
1 ... 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 ... 307